Condition
Methamphetamine
Total Trials
7
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
3 of 6 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (1)
P 1 (2)
P 2 (4)
Trial Status
Completed6
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06746831Phase 1Not Yet RecruitingPrimary
Methamphetamine Isomer Pharmacology in Humans
NCT04544124Not ApplicableCompletedPrimary
Delivering Contingency Management in Outpatient Addiction Treatment
NCT01723384Phase 2CompletedPrimary
Intermittent Naltrexone Among Polysubstance Users
NCT00345371Phase 2CompletedPrimary
Topiramate for the Treatment of Methamphetamine Dependence - 1
NCT00135785Phase 2CompletedPrimary
Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2
NCT00833443Phase 2CompletedPrimary
Study of Medical Treatment for Methamphetamine Addiction
NCT01174654Phase 1Completed
Development of a Methamphetamine Early Intervention
Showing all 7 trials